Discovery and Characterisation of Quinazolines and 8-Azaquinazolines as NLRP3 Agonists with Oral Bioavailability in Mice

Publication date: Available online 12 October 2023

Source: Bioorganic & Medicinal Chemistry Letters

Author(s): Daniel H. O' Donovan, David Baker, Giovanni Ciotta, Sébastien L. Degorce, Sylvain Demanze, Milly Dockerill, Leire Escudero-Ibarz, Lucy Ireland, Yumeng Mao, Martin J. Packer, James Robinson, Graeme Scarfe, Haoran Tang, Viia Valge-Archer

Discovery of <em>(E)-2-(Hydroxyimino)-N-(2 ((4methylpentyl)amino)ethyl)acetamide</em> (KR-27425) as a non-pyridinium oxime reactivator of paraoxon-inhibited acetylcholinesterase

Publication date: Available online 12 October 2023

Source: Bioorganic & Medicinal Chemistry Letters

Author(s): Avinash G Vishakantegowda, Berehe Solomon Girmay, Jin Soo Shin, Joo-Youn Lee, Sunjoo Ahn, Young-Sik Jung

Green synthesis and anti-biofilm activities of 3,5-disubstituted isoxazoline/isoxazole-linked secondary sulfonamide derivatives on <em>Pseudomonas aeruginosa</em>

Publication date: Available online 12 October 2023

Source: Bioorganic & Medicinal Chemistry Letters

Author(s): Ayoub El Mahmoudi, Anne-Sophie Tareau, Magalie Barreau, Sylvie Chevalier, Chaimae Hourma, Luc Demange, Rachid Benhida, Khalid Bougrin

Flexibility in the bridge of chalcone derivatives is important for the inhibition of cellular growth

Publication date: 15 October 2023

Source: Bioorganic & Medicinal Chemistry Letters, Volume 95

Author(s): Trevor M. Stantliff, Amber Hill, Mary Elaine Kuo, Hadley E. Neal, Tighe C. Harrod, Katy Goens, Mark Mashuta, Anna M. Christianson, Amanda J. Krzysiak

Discovery of marine phidianidine-based Nrf2 activators and their potential against oxLDL- and HG-induced injury in HUVECs

Publication date: 15 October 2023

Source: Bioorganic & Medicinal Chemistry Letters, Volume 95

Author(s): Juan Zhang, Yong-Si Cai, Hua-Long Ji, Mengqi Ma, Jin-He Zhang, Zhi-Qiang Cheng, Kai-Ming Wang, Cheng-Shi Jiang, Chunlin Zhuang, Yang Hu, Ning Meng